Seres Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MCRB for the last quarter is 64.00 k USD, and it's 79.35% lower compared to the previous quarter. The net income of Q4 23 is -41.25 M USD.